Sanofi clinches $2-bn vaccines deal with Translate Bio
The deal strengthens Sanofi’s credentials in a market engaged in a frantic race to find a safe and effective vaccine against the…
Author
Cipla to price remdesivir version for COVID-19 under 5,000 rupees
Cipla, in an e-mailed statement, did not provide details on when the treatment, called Cipremi, will be available
Gilead targets remdesivir supply for two million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, currently…
Bayer close to glyphosate settlement worth $8-10 billion: German business daily
The settlement is over claims that its glyphosate-based Roundup weedkiller causes cancer
Inovio gets $71 million from US defense department for COVID-19 vaccine device
Inovio, which began human testing of its vaccine in April, said it expects to report interim results from the trial later this…
Trials with Oxford COVID-19 vaccine start in Brazil
Trials will count on 2,000 health workers volunteers in Sao Paulo and 1,000 people in Rio de Janeiro
Sanofi eyes approval of COVID-19 vaccine by first half of 2021
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be…
Antibody levels in recovered COVID-19 patients decline quickly: research
The research highlights the risks of using COVID-19 ‘immunity passports’ and supports the prolonged use of public health…
Thai trials of COVID-19 vaccine reach make-or-break stage
Thirteen monkeys were immunized and the next two weeks will be critical in determining whether researchers can proceed with…
Chinese researchers launch phase-2 human test for possible coronavirus vaccine
IMBCAMS began a phase 2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing…